Beyond the Healthcare Super App: Why Medz.fit Is Building a Connected Ecosystem of Specialised Products

As healthcare platforms confront fragmented systems and diverse user needs, Bangladeshi healthtech startup Medz.fit is taking a different approach, developing specialised applications on shared infrastructure rather than relying on a single all-purpose product.

The digital health industry has spent years pursuing the idea of a single application that can bring together consultations, prescriptions, medical records, pharmacy services and patient management. But as healthcare providers and technology companies attempt to connect increasingly complex services, the limitations of the all-in-one model are becoming more apparent. The challenge is no longer simply putting more healthcare functions into one interface. It is making different services work together without adding complexity for patients and providers.

Across Southeast Asia, interoperability is becoming a more prominent part of that discussion. In March 2026, the World Health Organization (WHO), the Alliance for Health Policy and Systems Research and Temasek Foundation launched a three-year initiative to help ASEAN countries transition from paper-based records to secure, interoperable digital health wallets. The programme will use standards including HL7 FHIR and the International Patient Summary to enable health information to move more consistently between systems and providers.

The initiative reflects a broader challenge: healthcare information and services remain fragmented across institutions, platforms and national borders. For technology companies, this raises an important product strategy question. Should they build one application that attempts to serve every healthcare need, or develop specialised products that connect through shared infrastructure? Bangladesh-based Medz.fit is pursuing the latter approach.

The super app model promises convenience by bringing multiple services under one digital roof. In healthcare, however, the requirements of patients, doctors, pharmacists, hospitals and diagnostic providers vary considerably. A pharmacy needs inventory management and expiry tracking, while patients need accessible medical records, medicine information and treatment guidance. Clinical professionals require tools that fit established workflows.

Combining these functions into one interface can create a complicated user experience. Yet developing separate applications without connecting them can reproduce the fragmentation that digital health platforms are supposed to address.

The distinction is increasingly important across Asia. A WHO initiative launched in 2026 is working with Thailand, Indonesia and Laos on verifiable personal health records. Thailand already has its MorProm health super app, but its maternal and child health application, Khun Look, is not yet interoperable with it. WHO’s assessment identifies governance and institutional coordination, rather than technology alone, as significant barriers to connecting health information.

The direction of travel, therefore, is not necessarily towards more applications or fewer applications. It is towards systems that can exchange information securely while allowing different services to address specific needs.

Medz.fit’s Bet on Specialised Products

Medz.fit describes itself as a healthcare execution platform, with seven applications addressing different parts of the healthcare journey. Its portfolio includes Momota for family health records, RxFlow for prescription and care-plan workflows, MedzLens for medicine discovery and pharmacy access, and Aayna Khata for pharmacy retail operations. It also lists WithYou, Clozer and Zahra, which focus on specialised treatment and recovery needs.

The company says these products use shared technology infrastructure, including AI assistance, optical character recognition, notifications, analytics and offline synchronisation. The approach is intended to allow individual products to serve distinct user groups while drawing on common capabilities.

For founder and CEO Mahmud Hassan, this strategy reflects a shift in how the company thinks about healthcare technology. Rather than building one application with an expanding list of features, Medz.fit is attempting to address specific problems through focused products.

While conversing with AsiaTechDaily, Hassan said, “Today, we have seven live applications addressing different aspects of healthcare, from family health records and medicine information to clinical productivity and pharmacy operations.”

The model could give the company multiple entry points into the healthcare ecosystem. A pharmacy might begin with retail software, while a patient could first encounter the company through medicine discovery or family health records. The longer-term opportunity would depend on whether these products can connect meaningfully and create value beyond their individual functions.

Why Adoption Matters More Than Technical Sophistication

Medz.fit’s product strategy also emerged from an early lesson in pharmacy digitisation. The company initially developed a computer-vision AI-powered point-of-sale system. Although some pharmacy operators appreciated its capabilities, others were reluctant to introduce a system that required them to change established routines.

Hassan said the experience challenged the assumption that faster or more sophisticated technology would automatically find adoption.

“Technological efficiency does not automatically translate into behavioral adoption. And somewhere in these observations, I had my Eureka moment. Perhaps the problem was not that these people needed more advanced technology. Perhaps we had been asking them to adapt to technology that never understood how they actually worked.”

He added that the company subsequently changed its approach: “Instead of asking people to change their behavior to accommodate our software, I started asking how our software could accommodate their behavior, and gradually make their everyday work simpler, more organized, and safer.”

This is a significant consideration for healthtech companies operating in emerging markets, where independent pharmacies and healthcare providers may still rely on manual processes. The ability to fit into existing workflows can be as important as the technology itself.

Can the Model Scale Across Asian Markets?

A specialised-product strategy offers potential advantages, but it also introduces commercial challenges. Maintaining multiple applications requires investment in product development, customer acquisition, support and compliance. Shared infrastructure may reduce duplication, but it does not automatically establish demand or make the business commercially sustainable.

Medz.fit has reported an early cross-border signal through Aayna Khata, with approximately 13% of its users coming from Indonesia, according to Hassan. The company has also discussed localisation for other markets. However, the figure needs to be considered in context: the company has not disclosed the total user base or the proportion of active users. Regional expansion will also require adaptation to differences in pharmacy practices, healthcare regulation, languages and data protection requirements. ASEAN’s digital health landscape remains uneven, with countries at different levels of infrastructure readiness, regulatory development and digital literacy.

Hassan acknowledged that Medz.fit is still at an early stage of demonstrating its impact. “But I want to distinguish adoption from proven healthcare outcomes. We are still early, and we are not claiming that we have already demonstrated measurable improvements in prescription fulfillment or treatment adherence.”

For healthcare startups, building multiple applications may offer a way to address specialised needs without forcing every user into the same interface. But the success of this model will depend on what happens behind those interfaces. Products must exchange relevant information securely, users must find sustained value in them, and providers must see improvements in their workflows. For companies such as Medz.fit, the challenge is to demonstrate that shared infrastructure creates a coherent healthcare ecosystem rather than simply supporting a collection of separate applications.

The future of digital health may not belong to the biggest app or the platform with the most features. It may belong to companies that make specialised services work together, while keeping the experience simple for the people who depend on them.

Quick Takeaways

• Medz.fit is developing seven specialised healthcare applications on shared technology infrastructure rather than relying on a single all-in-one healthcare app.
• Its product portfolio covers family health records, digital prescriptions, medicine discovery, pharmacy operations and specialised treatment support.
• The company’s strategy reflects a broader challenge in digital health: connecting fragmented healthcare services while keeping individual products simple and relevant to their users.
• Founder and CEO Mahmud Hassan says Medz.fit’s early experience with an AI-powered pharmacy POS system showed that technological sophistication does not guarantee adoption.
• The company subsequently shifted towards designing products around existing user behaviour and pharmacy workflows.
• Approximately 13% of Aayna Khata users are reportedly from Indonesia, offering an early indication of potential cross-border demand.
• Regional expansion will require localisation to different healthcare regulations, pharmacy practices, languages and data protection requirements.
• Medz.fit has yet to demonstrate measurable improvements in prescription fulfilment or treatment adherence, making long-term adoption and healthcare outcomes important tests for its model.
• The article examines whether the future of digital health lies in specialised applications connected through shared infrastructure rather than one application attempting to do everything.